---
slug: psychedelic-harms
type: risk
subsection: psychological-medical
created: 2026-06-02
updated: 2026-06-07
summary: "The psychological, medical, and provider-setting harms that can follow psychedelic use: panic, destabilization, dangerous drug interactions, HPPD, ketamine bladder injury, and abuse by unqualified or predatory guides."
related:
  psychosis-awakening:
    relation: related
    note: "Psychedelic and psychedelic-like states can be read as awakening when they are actually mania, psychosis, or another crisis that needs care."
  medical-neglect:
    relation: related
    note: "Skipped screening, medication interactions, and treatment substituted by retreat promises are psychedelic-specific routes into medical neglect."
  guru-abuse:
    relation: related
    note: "The guide, therapist, shaman, or facilitator role can reproduce the same authority and boundary failures seen in guru abuse."
  breathwork:
    relation: related
    note: "Holotropic breathwork developed as a non-drug route into psychedelic-like states and shares some integration and destabilization concerns."
  spiritual-awakening:
    relation: related
    note: "Many psychedelic users interpret the experience as awakening; the harms can sit beside that interpretation."
  carlos-castaneda:
    relation: related
    note: "Castaneda is one of the earlier psychedelic-adjacent lineage nodes in the modern spiritual imagination."
  esalen-institute:
    relation: related
    note: "Esalen is a key site where psychedelic research, human-potential practice, and later non-drug altered-state methods overlapped."
---

# Psychedelic Harms

> **Risk**
>
> How a belief or practice can mislead, harm, exploit, or detach people from reality.

*The psychological, medical, and provider-setting harms that can follow psychedelic use when the substance, the person, the dose, the setting, or the guide is wrong for the moment.*

Psychedelics sit in a rare position inside modern spirituality. They can occasion the kind of opening practitioners describe as mystical, initiatory, or life-reordering, and they also put real pharmacology into a vulnerable mind and body. The same session can feel like revelation and still become a medical emergency.

The harm is not "psychedelics are bad." The harm is the collapse of discernment around them: treating intensity as safety, treating a guide as a clinician, treating a retreat intake form as medical screening, or assuming that a substance called medicine cannot injure.

## The Risk in One Sentence

Psychedelic harms occur when an altered-state practice produces panic, dangerous behavior, lasting perceptual disturbance, psychosis or mania, toxic drug interaction, organ injury, dependence, or provider abuse that the user, group, or facilitator is not prepared to recognize and manage.

## How It Presents

The acute version is the bad trip: terror, paranoia, disorientation, looping thoughts, overwhelming grief, or a conviction that something terrible must be done immediately. Most such experiences pass with calm support, but the dangerous edge appears when the person runs, drives, fights restraint, becomes suicidal, or loses contact with ordinary reality in a setting that can't keep them safe.

The medical version depends on the substance. MDMA can raise heart rate, blood pressure, and body temperature; in hot rooms, crowded parties, or long sessions, hyperthermia and hyponatremia can become life-threatening. Ayahuasca carries a different problem: the brew's MAOI activity can interact with serotonergic medications, stimulants, some antidepressants, and other drugs. Ketamine has its own profile. Heavy, repeated use is linked with dependence and ketamine-induced cystitis, a bladder injury pattern marked by urinary frequency, pain, bleeding, and sometimes upper-tract damage.

The longer-term version is quieter. Hallucinogen Persisting Perception Disorder, or HPPD, describes lingering visual disturbances after hallucinogen use: trails, halos, visual snow, afterimages, or distortions that don't stop when the session ends. Persistent psychosis or mania is less common, but it is one of the risks clinical trials screen hardest for, especially in people with personal or family histories of psychotic or bipolar disorders.

The provider-setting version is social, not chemical. A person under a psychedelic is unusually open, suggestible, embodied, and dependent on the room. That makes poor training, unclear touch boundaries, sexual misconduct, coercive interpretation, and post-session dependency serious harms, not side issues.

## Why People Fall Into It

The public story has raced ahead of the safeguards. Psychedelic-assisted therapy, ketamine clinics, ayahuasca retreats, microdosing, and plant-medicine circles are often described with the language of healing. That language isn't always wrong, but it can dull the ordinary caution people would bring to any strong psychoactive drug.

Set and setting are often named but not understood. A beautiful room, a playlist, and a confident guide do not replace psychiatric screening, medical history, medication review, emergency planning, and integration support. The person may also want the experience badly enough to minimize the contraindications: the bipolar family history, the SSRI, the heart condition, the recent psychotic break, the panic attacks, the retreat's vague intake process.

Communities can make the same mistake at group scale. If the shared story is that "the medicine gives you what you need," then distress is interpreted as lesson, purging, ego death, or resistance. Sometimes that is a useful frame. Sometimes it delays the moment when someone should call for medical or psychiatric help.

## Warning Signs

Watch for a facilitator who doesn't ask about medications, psychiatric history, cardiovascular history, pregnancy, seizures, or substance use. Watch for any setting with no clear emergency plan, no sober support, no way to leave safely, no explanation of consent around touch, or no aftercare beyond vague trust in the medicine.

The personal warning signs are just as concrete: a history of psychosis, mania, or bipolar I disorder; a close family history of psychotic or bipolar disorder; current use of serotonergic or stimulant medications, depending on the substance; serious heart disease; recent suicidal crisis; active substance dependence; or a belief that the session is necessary because ordinary care has failed you spiritually.

> **⚠️ When the session has become an emergency**
>
> Chest pain, seizure, overheating, severe confusion, loss of consciousness, command voices, suicidal intent, violent behavior, or days without sleep belong in emergency care. Peer support can help with fear and integration; it doesn't replace urgent medical or psychiatric help.

## Common Rationalizations

The rationalizations sound spiritual because they come from the field's own best language.

- "The medicine knows." This turns a substance into an authority and can excuse poor screening or unsafe facilitation.
- "A difficult trip is always healing." Some difficult experiences are meaningful. Some are trauma, delirium, toxicity, or psychosis.
- "Clinical rules don't apply to sacred medicine." The brew may be sacramental; the MAOI interaction is still pharmacology.
- "If you're scared, you're resisting." Fear can be resistance. It can also be the body's accurate signal that something is wrong.
- "Integration will fix it." Integration helps people make meaning after an experience. It can't undo bladder injury, serotonin toxicity, or an untreated manic episode.

## Likely Harms

The lightest harms are still disruptive: panic, shame, insomnia, derealization, relationship strain, and a destabilizing flood of material the person can't metabolize. The heavier harms can change a life. HPPD can leave someone frightened by visual distortions months after use. A psychotic or manic episode can lead to hospitalization, financial ruin, estrangement, or suicide risk, especially when the spiritual reading delays care.

The physical harms are more substance-specific. MDMA toxicity can involve hyperthermia, hyponatremia, cardiac dysrhythmia, seizures, rhabdomyolysis, liver injury, and death. Ayahuasca interactions can create a risk of serotonin toxicity or hypertensive crisis. Heavy ketamine use can injure the bladder badly enough to require urological care.

The social harms are harder to chart but no less real. A guide can use the intimacy of the session to claim special insight, install a private interpretation, cross sexual boundaries, or build dependency. The altered state doesn't create that abuse by itself. It gives an unaccountable person a room in which the participant is open, impaired, and primed to treat whatever happens as meaningful.

## Safer Alternatives

The repair begins before the substance. Treat screening as part of the practice, not as bureaucracy: current medications, psychiatric history, family history, cardiovascular risk, substance-use history, pregnancy, seizure history, and emergency contacts. If a facilitator doesn't take that seriously, don't let them guide the session.

Use legal, regulated, and clinically supervised settings where they exist. Where they don't exist, reduce the exposure: avoid mixing substances; use drug checking where available; don't dose alone; keep a sober sitter; do not drive; plan food, water, sleep, and a safe way home; and know in advance who will be called if the experience turns medical or psychiatric.

For difficult but non-emergency experiences, peer support lines such as Fireside Project can help during or after a session. For danger to self or others, call emergency services or a crisis line instead.

The deeper alternative is less glamorous: keep the experience in proportion. Psychedelics may open material a person has not reached by other means. They can also expose material faster than the person can hold it. A trustworthy guide, therapist, or community does not demand surrender to intensity. It helps the person stay in relationship with reality, the body, ordinary medical care, and the people who will still be there after the vision fades.

## Sources

- U.S. Food and Drug Administration, [*Psychedelic Drugs: Considerations for Clinical Investigations*](https://www.fda.gov/regulatory-information/search-fda-guidance-documents/psychedelic-drugs-considerations-clinical-investigations) (draft guidance, 2023) — FDA guidance on safety monitoring, abuse potential, psychotherapy design, and trial considerations for classic psychedelics and MDMA.
- Rick Figurasin, Vincent R. Lee, and Nicole J. Maguire, [*3,4-Methylenedioxymethamphetamine (MDMA) Toxicity*](https://www.ncbi.nlm.nih.gov/books/NBK538482/) (StatPearls / NCBI Bookshelf, updated 2024) — clinical overview of MDMA toxicity, including hyperthermia, hyponatremia, serotonin syndrome, dysrhythmias, seizures, rhabdomyolysis, and hepatic injury.
- Luís Fernando Tófoli et al., ["The Pharmacological Interaction of Compounds in Ayahuasca: A Systematic Review"](https://pmc.ncbi.nlm.nih.gov/articles/PMC7678905/) (*Journal of Psychoactive Drugs*, 2020) — review of ayahuasca's MAOI/DMT pharmacology and interaction concerns, including serotonergic medications and hypertensive-risk combinations.
- G. Martinotti et al., ["Hallucinogen Persisting Perception Disorder: Etiology, Clinical Features, and Therapeutic Perspectives"](https://pmc.ncbi.nlm.nih.gov/articles/PMC5870365/) (*Brain Sciences*, 2018) — review of HPPD, its visual symptoms, suspected triggers, psychiatric comorbidities, and treatment uncertainty.
- Dylan J. Anderson et al., ["Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug"](https://pmc.ncbi.nlm.nih.gov/articles/PMC9476224/) (*Urology Research and Practice*, 2022) — review of bladder and urinary-tract harms associated with frequent ketamine use.
- Janis Phelps, ["Developing Guidelines and Competencies for the Training of Psychedelic Therapists"](https://journals.sagepub.com/doi/10.1177/0022167817711304) (*Journal of Humanistic Psychology*, 2017) — early competency framework for psychedelic therapists, including knowledge of physical and psychological drug effects and ethical integrity.
- William Brennan et al., ["A Qualitative Exploration of Relational Ethical Challenges and Practices in Psychedelic Healing"](https://journals.sagepub.com/doi/10.1177/00221678211045265) (*Journal of Humanistic Psychology*, 2021) — interview study of underground practitioners describing boundary, touch, competence, and relational-ethics challenges in psychedelic healing contexts.
- Fireside Project, [Psychedelic Support Line](https://firesideproject.org/hotline) — peer-support resource for people during difficult psychedelic experiences or integration, cited here as harm-reduction infrastructure rather than medical emergency care.

---

- [Next: False Memory](false-memory.md)
- [Previous: Psychological & Medical Boundaries](psychological-medical.md)